Kotaka, M., Xu, R., Muro, K., Park, Y. S., Morita, S., Iwasa, S., . . . Kim, T. W. (2016). Study protocol of the Asian XELIRI ProjecT (AXEPT): A multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumab. Chin J Cancer.
Chicago Style aipamenaKotaka, Masahito, et al. "Study Protocol of the Asian XELIRI ProjecT (AXEPT): A Multinational, Randomized, Non-inferiority, Phase III Trial of Second-line Chemotherapy for Metastatic Colorectal Cancer, Comparing the Efficacy and Safety of XELIRI With or Without Bevacizumab Versus FOLFIRI With or Without Bevacizumab." Chin J Cancer 2016.
MLA aipamenaKotaka, Masahito, et al. "Study Protocol of the Asian XELIRI ProjecT (AXEPT): A Multinational, Randomized, Non-inferiority, Phase III Trial of Second-line Chemotherapy for Metastatic Colorectal Cancer, Comparing the Efficacy and Safety of XELIRI With or Without Bevacizumab Versus FOLFIRI With or Without Bevacizumab." Chin J Cancer 2016.